Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study

Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study

Advanced high-grade serous ovarian carcinoma is a serious malignant neoplasm with a late diagnosis and high mortality rate. Even when treated with standard therapy, such as surgery followed by carboplatin and paclitaxel chemotherapy, the prognosis remains unfavorable. Immunotherapy is a treatment al...

Full description

Bibliographic Details
Main Authors: Ana Paula Dergham, Caroline Busatta Vaz de Paula, Seigo Nagashima, Márcia Olandoski, Lucia de Noronha, Vanessa Santos Sotomaior
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Personalized Medicine
Subjects:
biomarkers
immunotherapy markers
advanced serous ovarian carcinoma
immunohistochemistry
p53
MSI
Online Access:https://www.mdpi.com/2075-4426/13/7/1045

Internet

https://www.mdpi.com/2075-4426/13/7/1045

Similar Items